Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa M Hess

Showing results (21-30 of 102) with videos related to

Pageof 11
Sort By:
BMC Cancer|April 26, 2023
Correction: Characteristics and outcomes of patients with RET-fusion positive non-small lung cancer in real-world practice in the United StatesLisa M Hess, Yimei Han, Yajun Emily Zhu, et al.
Advances in Hematology|January 9, 2023
Outcomes among Patients with Mantle Cell Lymphoma Post-Covalent BTK Inhibitor Therapy in the United States: A Real-World Electronic Medical Records StudyLisa M Hess, Yongmei Chen, Paolo B Abada, et al.
JCO Precision Oncology|June 23, 2022
Disparities in Biomarker Testing and Clinical Trial Enrollment Among Patients With Lung, Breast, or Colorectal Cancers in the United StatesDebora S Bruno, Lisa M Hess, Xiaohong Li, et al.
Journal of Medical Economics|December 1, 2022
Costs of biomarker testing among patients with metastatic lung or thyroid cancer in the USA: a real-world commercial claims database studyLisa M Hess, Diane Michael, Peter M Krein, et al.
Thyroid Research|February 13, 2022
Diagnostic characteristics, treatment patterns, and clinical outcomes for patients with advanced/metastatic medullary thyroid cancerRohan Parikh, Lisa M Hess, Elizabeth Esterberg, et al.
Cancer|July 29, 2010
Continued chemotherapy after complete response to primary therapy among women with advanced ovarian cancer: a meta-analysisLisa M Hess, Nan Rong, Patrick O Monahan, et al.
Perspectives in Health Information Management|April 26, 2019
Challenges of Using ICD-9-CM and ICD-10-CM Codes for Soft-Tissue Sarcoma in Databases for Health Services ResearchLisa M Hess, Yajun E Zhu, Tomoko Sugihara, et al.
Immunotherapy|June 18, 2021
Efficacy of immune checkpoint inhibitor therapy in patients with <i>RET</i> fusion-positive non-small-cell lung cancerNaleen Raj Bhandari, Lisa M Hess, Yimei Han, et al.
Journal of the National Cancer Institute|January 2, 2014
Re: Cost-effectiveness analysis of screening for KRAS and BRAF mutations in metastatic colorectal cancerLisa M Hess, Gebra Carter, Lee Smolen, et al.
The Patient|July 31, 2014
Preference elicitation tool for abnormal uterine bleeding treatment: a randomized controlled trialLisa M Hess, Abigail Litwiller, John Byron, et al.
Pageof 11

Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
BMC Cancer|April 26, 2023
Correction: Characteristics and outcomes of patients with RET-fusion positive non-small lung cancer in real-world practice in the United StatesLisa M Hess, Yimei Han, Yajun Emily Zhu, et al.
Advances in Hematology|January 9, 2023
Outcomes among Patients with Mantle Cell Lymphoma Post-Covalent BTK Inhibitor Therapy in the United States: A Real-World Electronic Medical Records StudyLisa M Hess, Yongmei Chen, Paolo B Abada, et al.
JCO Precision Oncology|June 23, 2022
Disparities in Biomarker Testing and Clinical Trial Enrollment Among Patients With Lung, Breast, or Colorectal Cancers in the United StatesDebora S Bruno, Lisa M Hess, Xiaohong Li, et al.
Journal of Medical Economics|December 1, 2022
Costs of biomarker testing among patients with metastatic lung or thyroid cancer in the USA: a real-world commercial claims database studyLisa M Hess, Diane Michael, Peter M Krein, et al.
Thyroid Research|February 13, 2022
Diagnostic characteristics, treatment patterns, and clinical outcomes for patients with advanced/metastatic medullary thyroid cancerRohan Parikh, Lisa M Hess, Elizabeth Esterberg, et al.
Cancer|July 29, 2010
Continued chemotherapy after complete response to primary therapy among women with advanced ovarian cancer: a meta-analysisLisa M Hess, Nan Rong, Patrick O Monahan, et al.
Perspectives in Health Information Management|April 26, 2019
Challenges of Using ICD-9-CM and ICD-10-CM Codes for Soft-Tissue Sarcoma in Databases for Health Services ResearchLisa M Hess, Yajun E Zhu, Tomoko Sugihara, et al.
Immunotherapy|June 18, 2021
Efficacy of immune checkpoint inhibitor therapy in patients with <i>RET</i> fusion-positive non-small-cell lung cancerNaleen Raj Bhandari, Lisa M Hess, Yimei Han, et al.
Journal of the National Cancer Institute|January 2, 2014
Re: Cost-effectiveness analysis of screening for KRAS and BRAF mutations in metastatic colorectal cancerLisa M Hess, Gebra Carter, Lee Smolen, et al.
The Patient|July 31, 2014
Preference elicitation tool for abnormal uterine bleeding treatment: a randomized controlled trialLisa M Hess, Abigail Litwiller, John Byron, et al.
Pageof 11